India, Feb. 25 -- image credit- freepik

SteinCares, a leading specialty healthcare company in Latin America, and Karnataka-basedShilpa Biologicals (SB), a fully integrated biopharmaceutical subsidiary ofShilpa Medicare, have announced a strategic licensing agreement to commercialize a biosimilar across Latin America.

Under the agreement, SteinCares will hold exclusive rights to register, commercialise, and distribute biosimilar across the region while SB will complete product development and commercial manufacturing from its facility in Dharwad.

The partnership brings together SB's expertise in biologics development and high-quality commercial manufacturing with SteinCares' integrated regional platform.

Mitchell Waserstein, CEO, Stein...